Strome Group, Inc.

10% OwnerZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Oct 30, 2023
Net Buying
Open-Market Buys
$200K
Open-Market Sells
$0
Net Open-Market Flow
$200K
Transactions
11
2 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2021Conversion(C)326K$8.00$2.6M326K
Jun 2, 2021Buy(P)40K$4.99$200K204K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 20, 2022Other(J)104K$00
Nov 20, 2022Other(J)4K$00
Nov 20, 2022Other(J)208K$00
Nov 20, 2022Other(J)8K$00
Nov 20, 2022Other(J)3K$00
Sep 25, 2022Other(J)3K$00
Jul 24, 2022Other(J)3K$00
Jun 2, 2021Buy(P)40K$0.01$40040K
Jun 2, 2021Conversion(C)2.2M$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001793373-23-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ZIVO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001793373-23-000005"
Ask your agent
Use Arkolith to summarize insider buying and selling at Zivo Bioscience, Inc.
over the last 90 days and cite the filings.